Literature DB >> 27941780

Good responses but high TRM in adult patients after MSC therapy for GvHD.

U Salmenniemi1, M Itälä-Remes1, J Nystedt2, M Putkonen1, R Niittyvuopio3, K Vettenranta4, M Korhonen2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27941780     DOI： 10.1038/bmt.2016.317

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.

Authors:  Lynne M Ball; Maria E Bernardo; Helene Roelofs; Maarten J D van Tol; Benedetta Contoli; Jaap Jan Zwaginga; Maria Antonia Avanzini; Antonella Conforti; Alice Bertaina; Giovanna Giorgiani; Cornelia M Jol-van der Zijde; Marco Zecca; Katarina Le Blanc; Francesco Frassoni; Rudolph Maarten Egeler; Willem E Fibbe; Arjan C Lankester; Franco Locatelli
Journal:  Br J Haematol       Date:  2013-08-31       Impact factor: 6.998

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

3.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

Review 4.  Improved accuracy of acute graft-versus-host disease staging among multiple centers.

Authors:  John E Levine; William J Hogan; Andrew C Harris; Mark R Litzow; Yvonne A Efebera; Steven M Devine; Ran Reshef; James L M Ferrara
Journal:  Best Pract Res Clin Haematol       Date:  2014-10-15       Impact factor: 3.020

Review 5.  First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

Authors:  Paul J Martin; J Douglas Rizzo; John R Wingard; Karen Ballen; Peter T Curtin; Corey Cutler; Mark R Litzow; Yago Nieto; Bipin N Savani; Jeffrey R Schriber; Paul J Shaughnessy; Donna A Wall; Paul A Carpenter
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-14       Impact factor: 5.742

Review 6.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

7.  Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome.

Authors:  Felix von Dalowski; Michael Kramer; Martin Wermke; Rebekka Wehner; Christoph Röllig; Nael Alakel; Friedrich Stölzel; Stefani Parmentier; Katja Sockel; Mathias Krech; Marc Schmitz; Uwe Platzbecker; Johannes Schetelig; Martin Bornhäuser; Malte von Bonin
Journal:  Stem Cells       Date:  2015-10-13       Impact factor: 6.277

8.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

9.  A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells.

Authors:  Anita Laitinen; Sofia Oja; Lotta Kilpinen; Tanja Kaartinen; Johanna Möller; Saara Laitinen; Matti Korhonen; Johanna Nystedt
Journal:  Cytotechnology       Date:  2015-03-17       Impact factor: 2.058

10.  Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Xiaomei Chen; Chunyan Wang; Jin Yin; Jinhuan Xu; Jia Wei; Yicheng Zhang
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240
View more
  26 in total

Review 1.  Mesenchymal stromal cells in hematopoietic cell transplantation.

Authors:  Andre J Burnham; Lisa P Daley-Bauer; Edwin M Horwitz
Journal:  Blood Adv       Date:  2020-11-24

2.  Inpatient Management of Mucocutaneous GVHD.

Authors:  Toral Vaidya; Christian Menzer; Doris M Ponce; Alina Markova
Journal:  Curr Dermatol Rep       Date:  2019-11-11

3.  Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD.

Authors:  Mayela Mendt; May Daher; Rafet Basar; Mayra Shanley; Bijender Kumar; Francesca Lim Wei Inng; Sunil Acharya; Hila Shaim; Natalie Fowlkes; Jamie P Tran; Elif Gokdemir; Nadima Uprety; Ana K Nunez-Cortes; Emily Ensley; Thao Mai; Lucila N Kerbauy; Luciana Melo-Garcia; Paul Lin; Yifei Shen; Vakul Mohanty; JunJun Lu; Sufang Li; Vandana Nandivada; Jing Wang; Pinaki Banerjee; Francia Reyes-Silva; Enli Liu; Sonny Ang; April Gilbert; Ye Li; Xinhai Wan; Jun Gu; Ming Zhao; Natalia Baran; Luis Muniz-Feliciano; Jeffrey Wilson; Indreshpal Kaur; Mihai Gagea; Marina Konopleva; David Marin; Guilin Tang; Ken Chen; Richard Champlin; Katayoun Rezvani; Elizabeth J Shpall
Journal:  Front Immunol       Date:  2021-05-04       Impact factor: 7.561

4.  Automated image analysis detects aging in clinical-grade mesenchymal stromal cell cultures.

Authors:  S Oja; P Komulainen; A Penttilä; J Nystedt; M Korhonen
Journal:  Stem Cell Res Ther       Date:  2018-01-10       Impact factor: 6.832

5.  Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.

Authors:  Joni Keto; Tanja Kaartinen; Urpu Salmenniemi; Johanna Castrén; Jukka Partanen; Arno Hänninen; Matti Korhonen; Kaarina Lähteenmäki; Maija Itälä-Remes; Johanna Nystedt
Journal:  Mol Ther Methods Clin Dev       Date:  2018-02-08       Impact factor: 6.698

6.  Associations of clinical outcomes and MRI findings in intra-articular administration of autologous adipose-derived stem cells for knee osteoarthritis.

Authors:  Junya Higuchi; Ryota Yamagami; Takumi Matsumoto; Tomohiro Terao; Keita Inoue; Shinsaku Tsuji; Yuji Maenohara; Tokio Matsuzaki; Ryota Chijimatsu; Yasunori Omata; Fumiko Yano; Sakae Tanaka; Taku Saito
Journal:  Regen Ther       Date:  2020-05-25       Impact factor: 3.419

7.  HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study.

Authors:  Marta Grau-Vorster; Anita Laitinen; Johanna Nystedt; Joaquim Vives
Journal:  Stem Cell Res Ther       Date:  2019-06-13       Impact factor: 6.832

8.  Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).

Authors:  Peter Bader; Zyrafete Kuçi; Shahrzad Bakhtiar; Oliver Basu; Gesine Bug; Michael Dennis; Johann Greil; Aniko Barta; Krisztián M Kállay; Peter Lang; Giovanna Lucchini; Raj Pol; Ansgar Schulz; Karl-Walter Sykora; Irene von Luettichau; Grit Herter-Sprie; Mohammad Ashab Uddin; Phil Jenkin; Abdulrahman Alsultan; Jochen Buechner; Jerry Stein; Agnes Kelemen; Andrea Jarisch; Jan Soerensen; Emilia Salzmann-Manrique; Martin Hutter; Richard Schäfer; Erhard Seifried; Thomas Klingebiel; Halvard Bonig; Selim Kuçi
Journal:  Bone Marrow Transplant       Date:  2018-01-29       Impact factor: 5.483

Review 9.  Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers.

Authors:  Tik Shing Cheung; Giuliana Minani Bertolino; Chiara Giacomini; Martin Bornhäuser; Francesco Dazzi; Antonio Galleu
Journal:  Front Immunol       Date:  2020-06-25       Impact factor: 7.561

10.  The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes.

Authors:  Sofia Oja; Tanja Kaartinen; Marja Ahti; Matti Korhonen; Anita Laitinen; Johanna Nystedt
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.